Business Description
CME Group Inc
NAICS : 523210
SIC : 6231
20 South Wacker Drive, Chicago, IL, USA, 60606
Compare
Compare
Traded in other countries / regions
CMEG.Austria
•
CHME34.Brazil
•
MX4A.Germany
•
CME.Mexico
•
0HR2.UK
•
CME.USA
Description
Based in Chicago, CME Group operates exchanges giving investors, suppliers, and businesses the ability to trade futures and derivatives based on interest rates, equity indexes, foreign currencies, energy, metals, and commodities. The CME was founded in 1898 and in 2002 completed its initial public offering. Since then, CME Group has consolidated parts of the industry by merging with crosstown rival, CBOT Holdings in 2007 before acquiring Nymex Holdings in 2008 and NEX in 2018. In addition, the company has a 27% stake in S&P/Dow Jones Indices LLC, making the Chicago Mercantile Exchange the exclusive venue to trade and clear S&P futures contracts. Through CME's acquisition of NEX in 2018 it has also expanded into cash foreign exchange, fixed income trading, and collateral optimization.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.58 | |||||
| Equity-to-Asset | 0.16 | |||||
| Debt-to-Equity | 0.12 | |||||
| Debt-to-EBITDA | 0.82 | |||||
| Interest Coverage | 17.18 | |||||
| Piotroski F-Score | 4/9 | |||||
| Altman Z-Score | 0.46 | |||||
| Beneish M-Score | -2.36 | |||||
| WACC vs ROIC | ||||||
Growth Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 1.4 | |||||
| 3-Year EBITDA Growth Rate | 5.7 | |||||
| 3-Year EPS without NRI Growth Rate | 8.5 | |||||
| 3-Year FCF Growth Rate | -2.1 | |||||
| 3-Year Book Growth Rate | 1.7 | |||||
| Future 3-5Y EPS without NRI Growth Rate Industry Rank | 4.58 | |||||
| Future 3-5Y Total Revenue Growth Rate Industry Rank | 3.03 |
Momentum Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 74.21 | |||||
| 9-Day RSI | 63.83 | |||||
| 14-Day RSI | 58.12 | |||||
| 6-1 Month Momentum % | -15.45 | |||||
| 12-1 Month Momentum % | -1.68 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.02 | |||||
| Quick Ratio | 1.02 | |||||
| Cash Ratio | 0.01 | |||||
| Days Sales Outstanding | 39.29 | |||||
| Days Payable | 31.13 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 1.83 | |||||
| Dividend Payout Ratio | 0.47 | |||||
| 3-Year Dividend Growth Rate | 8.7 | |||||
| Forward Dividend Yield % | 1.93 | |||||
| 5-Year Yield-on-Cost % | 2.75 | |||||
| 3-Year Average Share Buyback Ratio | -0.2 |
Profitability Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 84.08 | |||||
| Operating Margin % | 58.96 | |||||
| Net Margin % | 60.43 | |||||
| ROE % | 10.53 | |||||
| ROA % | 1.55 | |||||
| ROIC % | 1.21 | |||||
| ROC (Joel Greenblatt) % | 356.12 | |||||
| ROCE % | 10.42 | |||||
| Years of Profitability over Past 10-Year | 10 |
GF Value Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 25.81 | |||||
| Forward PE Ratio | 26.31 | |||||
| PE Ratio without NRI | 25.81 | |||||
| Shiller PE Ratio | 31.47 | |||||
| Price-to-Owner-Earnings | 24.38 | |||||
| PEG Ratio | 4.3 | |||||
| PS Ratio | 15.41 | |||||
| PB Ratio | 2.65 | |||||
| Price-to-Free-Cash-Flow | 28.53 | |||||
| Price-to-Operating-Cash-Flow | 27.48 | |||||
| EV-to-EBIT | 19.8 | |||||
| EV-to-Forward-EBIT | 24.16 | |||||
| EV-to-EBITDA | 18.05 | |||||
| EV-to-Forward-EBITDA | 21.71 | |||||
| EV-to-Revenue | 15.73 | |||||
| EV-to-Forward-Revenue | 14.97 | |||||
| EV-to-FCF | 28.92 | |||||
| Price-to-Projected-FCF | 1.64 | |||||
| Price-to-DCF (Earnings Based) | 1.5 | |||||
| Price-to-DCF (FCF Based) | 1.59 | |||||
| Price-to-Median-PS-Value | 1.32 | |||||
| Price-to-Peter-Lynch-Fair-Value | 4.95 | |||||
| Earnings Yield (Greenblatt) % | 5.04 | |||||
| Forward Rate of Return (Yacktman) % | 8.36 |
Guru Trades
See DetailsEMBED
SAVE
Insider Trades
See DetailsEMBED
SAVE
Gurus Latest Trades with NAS:CME
Executives
EMBED
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 4,841 | ||
| EPS (TTM) ($) | 8.06 | ||
| Beta | 0.63 | ||
| Volatility % | 21.96 | ||
| 14-Day RSI | 58.12 | ||
| 14-Day ATR ($) | 4.687683 | ||
| 20-Day SMA ($) | 201.266 | ||
| 12-1 Month Momentum % | -1.68 | ||
| 52-Week Range ($) | 185.79 - 256.94 | ||
| Shares Outstanding (Mil) | 359.44 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
CME Group Inc Filings
| Document | Form | Filing Date | ||
|---|---|---|---|---|
| No Filing Data | ||||